Cargando…
Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis
PURPOSE: Carbonic anhydrase inhibitors (CAIs) reduce macular schisis in patients with X-linked retinoschisis (XLRS). The purpose of this study was to determine if CAIs reduce the incidence of complications from XLRS, including macular atrophy, retinal tears, and retinal detachment (RD), the most com...
Autores principales: | Wey, Stephanie, Brill, Daniel A., Miraldi Utz, Virginia, Sisk, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657813/ https://www.ncbi.nlm.nih.gov/pubmed/38020097 http://dx.doi.org/10.3389/fmed.2023.1281068 |
Ejemplares similares
-
Longitudinal Photoreceptor Phenotype Observation and Therapeutic Evaluation of a Carbonic Anhydrase Inhibitor in a X-Linked Retinoschisis Mouse Model
por: Liu, Meng, et al.
Publicado: (2022) -
Dramatic regression of macular and peripheral retinoschisis with dorzolamide 2 % in X-linked retinoschisis: a case report
por: Sadaka, Ama, et al.
Publicado: (2016) -
Papillomacular retinoschisis associated with glaucoma: Response to topical carbonic anhydrase inhibitor
por: Haruta, Masatoshi, et al.
Publicado: (2020) -
X-linked retinoschisis
por: Dubey, Devashish, et al.
Publicado: (2020) -
Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials
por: Fenner, Beau J., et al.
Publicado: (2023)